Print This Page Email This Page Share on LinkedIn Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Europe/Mideast BASF to Shutter or Scale Back 180 Plants as Demand ShrinksSAFC: The Age of the Blockbuster Drug has ‘Disappeared’Merck Adds to Biotech CenterGSK to Shut U.K. Manufacturing Plant by 2013Ineos Seeks Waivers from Banks Related Stories U.S. FDA to Establish Pharmaceutical Inspection Offices in China, EU Plans New Measures Against Counterfeit DrugsAllessaChemie Enjoys Rapid Growth Trajectory, Develops Novel R&D ModelPhenol Fire Closes Channel TunnelWacker Adds to Biologics Capacity in GermanyCPhI: Confidence Abounds

Chemical Week Magazine :: Business & Finance :: Europe/Mideast

October 6, 2008

CPhI: Dow Brings Synthetic Glycerine Business Back Under its Domain

Deepti Ramesh in Frankfurt

Dow told CW at the recent CPhI expo in Frankfurt that since August, it has brought back its Optim synthetic glycerine business to the main Dow Chemical group, after a period of about three years. The business is now focused mainly on pharmaceutical customers...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers